Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
TUSAMITAMAB RAVTANSINE
Not marketed
Neoplasm
TES16382TusaRav-QTNCT05429762Summary
VALPROATE
Caprelsa
Thyroid Cancer
D4200C00008 (LPS14954)NANCT00098345
VALPROATE
Caprelsa
Colorectal Cancer
D4200C00047 (LPS15025)NANCT00500292
VALPROATE
Caprelsa
Non Small Cell Lung Cancer
D4200C00057NANCT00364351
VALPROATE
Depakine
Bipolar Disorder
DPKOT_L_01567GEVANSNCT00477373Summary
VALPROATE
Depakine
Bipolar I Disorder
EFC_5196NEW DELISummary
VALPROATE
Depakine
Epilepsy
L_8923NASummary
VALPROATE
Depakine
Epilepsy
L_8971VAPOPNCT00385411Summary
VALPROATE
Depakine
Bipolar Disorder
L_8979NASummary
VALPROATE
Depakine
Bipolar Disorder
L_9387NANCT00431522Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted